Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Rocket Pharmaceuticals (RCKT) over the last 5 years, with Q2 2023 value amounting to $47000.0.

  • Rocket Pharmaceuticals' Treasury Shares changed N/A to $47000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $47000.0, marking a year-over-year change of. This contributed to the annual value of $47000.0 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Rocket Pharmaceuticals' Treasury Shares is $5.5 million, which was up 25144.18% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, Rocket Pharmaceuticals' Treasury Shares peaked at $5.7 million during Q1 2024, and registered a low of $2571.0 during Q1 2023.
  • Its 5-year average for Treasury Shares is $1.9 million, with a median of $1.2 million in 2021.
  • In the last 5 years, Rocket Pharmaceuticals' Treasury Shares tumbled by 9206.59% in 2019 and then plummeted by 7790.7% in 2020.
  • Quarter analysis of 4 years shows Rocket Pharmaceuticals' Treasury Shares stood at $53000.0 in 2019, then surged by 43.4% to $76000.0 in 2020, then tumbled by 38.16% to $47000.0 in 2022, then changed by 0.0% to $47000.0 in 2023.
  • Its last three reported values are $47000.0 in Q2 2023, $47000.0 for Q1 2023, and $47000.0 during Q4 2022.